{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:09:57Z","timestamp":1791850197682,"version":"4.3.4"},"publisher-location":"Cham","reference-count":99,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031920325","type":"print"},{"value":"9783031920332","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-92033-2_13","type":"book-chapter","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T17:44:16Z","timestamp":1751478256000},"page":"179-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Anemia of Inflammation"],"prefix":"10.1007","author":[{"given":"Lukas","family":"Lanser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"4","key":"13_CR1","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.resinv.2022.03.006","volume":"60","author":"M Alisamir","year":"2022","unstructured":"Alisamir M, Ebrahimi M, Rahim F (2022) Anemia in chronic obstructive pulmonary disease: a systematic review. Respir Investig 60(4):510\u2013521. https:\/\/doi.org\/10.1016\/j.resinv.2022.03.006","journal-title":"Respir Investig"},{"issue":"1","key":"13_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/circulationaha.118.030099","volume":"138","author":"IS Anand","year":"2018","unstructured":"Anand IS, Gupta P (2018) Anemia and iron deficiency in heart failure: current concepts and emerging therapies. Circulation 138(1):80\u201398. https:\/\/doi.org\/10.1161\/circulationaha.118.030099","journal-title":"Circulation"},{"issue":"15","key":"13_CR3","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1182\/blood-2011-04-351957","volume":"118","author":"AE Armitage","year":"2011","unstructured":"Armitage AE, Eddowes LA, Gileadi U, Cole S, Spottiswoode N, Selvakumar TA, Ho LP, Townsend AR, Drakesmith H (2011) Hepcidin regulation by innate immune and infectious stimuli. Blood 118(15):4129\u20134139. https:\/\/doi.org\/10.1182\/blood-2011-04-351957","journal-title":"Blood"},{"issue":"8","key":"13_CR4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1182\/blood-2017-05-786590","volume":"131","author":"S Aschemeyer","year":"2018","unstructured":"Aschemeyer S, Qiao B, Stefanova D, Valore EV, Sek AC, Ruwe TA, Vieth KR, Jung G, Casu C, Rivella S, Jormakka M, Mackenzie B, Ganz T, Nemeth E (2018) Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin. Blood 131(8):899\u2013910. https:\/\/doi.org\/10.1182\/blood-2017-05-786590","journal-title":"Blood"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/bs.vh.2019.01.008","volume-title":"Vitamins and hormones","author":"M Asperti","year":"2019","unstructured":"Asperti M, Denardo A, Gryzik M, Arosio P, Poli M (2019) Chapter eight \u2013 The role of heparin, heparanase and heparan sulfates in hepcidin regulation. In: Litwack G (ed) Vitamins and hormones, vol 110. Academic Press, pp 157\u2013188. https:\/\/doi.org\/10.1016\/bs.vh.2019.01.008"},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2147\/ijgm.S17788","volume":"4","author":"K Aspuru","year":"2011","unstructured":"Aspuru K, Villa C, Bermejo F, Herrero P, L\u00f3pez SG (2011) Optimal management of iron deficiency anemia due to poor dietary intake. Int J Gen Med 4:741\u2013750. https:\/\/doi.org\/10.2147\/ijgm.S17788","journal-title":"Int J Gen Med"},{"issue":"13","key":"13_CR7","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1182\/blood-2016-09-740092","volume":"129","author":"M Asshoff","year":"2017","unstructured":"Asshoff M, Petzer V, Warr MR, Haschka D, Tymoszuk P, Demetz E, Seifert M, Posch W, Nairz M, Maciejewski P, Fowles P, Burns CJ, Smith G, Wagner K-U, Weiss G, Whitney JA, Theurl I (2017) Momelotinib inhibits ACVR1\/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents. Blood 129(13):1823\u20131830. https:\/\/doi.org\/10.1182\/blood-2016-09-740092","journal-title":"Blood"},{"issue":"6","key":"13_CR8","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.kint.2021.03.020","volume":"99","author":"JL Babitt","year":"2021","unstructured":"Babitt JL, Eisenga MF, Haase VH, Kshirsagar AV, Levin A, Locatelli F, Ma\u0142yszko J, Swinkels DW, Tarng DC, Cheung M, Jadoul M, Winkelmayer WC, Dr\u00fceke TB (2021) Controversies in optimal anemia management: conclusions from a kidney disease: improving global outcomes (KDIGO) conference. Kidney Int 99(6):1280\u20131295. https:\/\/doi.org\/10.1016\/j.kint.2021.03.020","journal-title":"Kidney Int"},{"issue":"6487","key":"13_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1126\/science.aau6481","volume":"368","author":"NJ Bessman","year":"2020","unstructured":"Bessman NJ, Mathieu JRR, Renassia C, Zhou L, Fung TC, Fernandez KC, Austin C, Moeller JB, Zumerle S, Louis S, Vaulont S, Ajami NJ, Sokol H, Putzel GG, Arvedson T, Sockolow RE, Lakhal-Littleton S, Cloonan SM, Arora M, Peyssonnaux C, Sonnenberg GF (2020) Dendritic cell-derived hepcidin sequesters iron from the microbiota to promote mucosal healing. Science 368(6487):186\u2013189. https:\/\/doi.org\/10.1126\/science.aau6481","journal-title":"Science"},{"issue":"2","key":"13_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000002308","volume":"95","author":"S Bonovas","year":"2016","unstructured":"Bonovas S, Fiorino G, Allocca M, Lytras T, Tsantes A, Peyrin-Biroulet L, Danese S (2016) Intravenous versus oral iron for the treatment of anemia in inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 95(2):e2308. https:\/\/doi.org\/10.1097\/md.0000000000002308","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"13_CR11","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1111\/bph.13433","volume":"173","author":"M Boyce","year":"2016","unstructured":"Boyce M, Warrington S, Cortezi B, Z\u00f6llner S, Vaul\u00e9on S, Swinkels DW, Summo L, Schwoebel F, Riecke K (2016) Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects. Br J Pharmacol 173(10):1580\u20131588. https:\/\/doi.org\/10.1111\/bph.13433","journal-title":"Br J Pharmacol"},{"issue":"4","key":"13_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/ph11040094","volume":"11","author":"F Busti","year":"2018","unstructured":"Busti F, Marchi G, Ugolini S, Castagna A, Girelli D (2018) Anemia and iron deficiency in cancer patients: role of iron replacement therapy. Pharmaceuticals 11(4):94","journal-title":"Pharmaceuticals"},{"key":"13_CR13","doi-asserted-by":"publisher","unstructured":"Caiado F, Pietras EM, Manz MG (2021) Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection. J Exp Med 218(7). https:\/\/doi.org\/10.1084\/jem.20201541","DOI":"10.1084\/jem.20201541"},{"issue":"19","key":"13_CR14","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1056\/NEJMra1401038","volume":"372","author":"C Camaschella","year":"2015","unstructured":"Camaschella C (2015) Iron-deficiency anemia. N Engl J Med 372(19):1832\u20131843. https:\/\/doi.org\/10.1056\/NEJMra1401038","journal-title":"N Engl J Med"},{"issue":"15","key":"13_CR15","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1182\/blood.2020010562","volume":"138","author":"CI Cercamondi","year":"2021","unstructured":"Cercamondi CI, Stoffel NU, Moretti D, Zoller T, Swinkels DW, Zeder C, Mhimibra F, Hella J, Fenner L, Zimmermann MB (2021) Iron homeostasis during anemia of inflammation: a prospective study of patients with tuberculosis. Blood 138(15):1293\u20131303. https:\/\/doi.org\/10.1182\/blood.2020010562","journal-title":"Blood"},{"issue":"14","key":"13_CR16","doi-asserted-by":"publisher","first-page":"9795","DOI":"10.1074\/jbc.M113.527150","volume":"289","author":"LM Coe","year":"2014","unstructured":"Coe LM, Madathil SV, Casu C, Lanske B, Rivella S, Sitara D (2014) FGF-23 is a negative regulator of prenatal and postnatal erythropoiesis. J Biol Chem 289(14):9795\u20139810. https:\/\/doi.org\/10.1074\/jbc.M113.527150","journal-title":"J Biol Chem"},{"issue":"17","key":"13_CR17","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.3390\/ijms20174195","volume":"20","author":"B Czaya","year":"2019","unstructured":"Czaya B, Faul C (2019) The role of fibroblast growth factor 23 in inflammation and anemia. Int J Mol Sci 20(17):4195. https:\/\/doi.org\/10.3390\/ijms20174195","journal-title":"Int J Mol Sci"},{"issue":"6","key":"13_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/s0022-2143(03)00041-6","volume":"141","author":"G Dallalio","year":"2003","unstructured":"Dallalio G, Means RT Jr (2003) Effects of oxidative stress on human erythroid colony formation: modulation by gamma-interferon. J Lab Clin Med 141(6):395\u2013400. https:\/\/doi.org\/10.1016\/s0022-2143(03)00041-6","journal-title":"J Lab Clin Med"},{"issue":"1","key":"13_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3324\/haematol.2022.281149","volume":"108","author":"LV De Souza","year":"2023","unstructured":"De Souza LV, Hoffmann A, Fischer C, Petzer V, Asshoff M, Theurl I, Tymoszuk P, Seifert M, Brigo N, Hilbe R, Demetz E, Von Raffay L, Berger S, Barros-Pinkelnig M, Weiss G (2023) Comparative analysis of oral and intravenous iron therapy in rat models of inflammatory anemia and iron deficiency. Haematologica 108(1):135\u2013149. https:\/\/doi.org\/10.3324\/haematol.2022.281149","journal-title":"Haematologica"},{"issue":"1","key":"13_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1042\/bj20071474","volume":"411","author":"C Delaby","year":"2008","unstructured":"Delaby C, Pilard N, Puy H, Canonne-Hergaux F (2008) Sequential regulation of ferroportin expression after erythrophagocytosis in murine macrophages: early mRNA induction by haem, followed by iron-dependent protein expression. Biochem J 411(1):123\u2013131. https:\/\/doi.org\/10.1042\/bj20071474","journal-title":"Biochem J"},{"issue":"3","key":"13_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","volume":"9","author":"AU Dignass","year":"2015","unstructured":"Dignass AU, Gasche C, Bettenworth D, Birgeg\u00e5rd G, Danese S, Gisbert JP, Gomollon F, Iqbal T, Katsanos K, Koutroubakis I, Magro F, Savoye G, Stein J, Vavricka S, Crohn\u2019s tE, Organisation C (2015) European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohn\u2019s Colitis 9(3):211\u2013222. https:\/\/doi.org\/10.1093\/ecco-jcc\/jju009","journal-title":"J Crohn\u2019s Colitis"},{"issue":"1","key":"13_CR22","doi-asserted-by":"publisher","first-page":"9394060","DOI":"10.1155\/2018\/9394060","volume":"2018","author":"A Dignass","year":"2018","unstructured":"Dignass A, Farrag K, Stein J (2018) Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions. Int J Chronic Dis 2018(1):9394060. https:\/\/doi.org\/10.1155\/2018\/9394060","journal-title":"Int J Chronic Dis"},{"issue":"2","key":"13_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/tme.12505","volume":"28","author":"AB Docherty","year":"2018","unstructured":"Docherty AB, Turgeon AF, Walsh TS (2018) Best practice in critical care: anaemia in acute and critical illness. Transfus Med 28(2):181\u2013189. https:\/\/doi.org\/10.1111\/tme.12505","journal-title":"Transfus Med"},{"issue":"5","key":"13_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.cmet.2015.09.006","volume":"22","author":"H Drakesmith","year":"2015","unstructured":"Drakesmith H, Nemeth E, Ganz T (2015) Ironing out Ferroportin. Cell Metab 22(5):777\u2013787. https:\/\/doi.org\/10.1016\/j.cmet.2015.09.006","journal-title":"Cell Metab"},{"key":"13_CR25","doi-asserted-by":"publisher","unstructured":"Duminuco A, Chifotides HT, Giallongo S, Giallongo C, Tibullo D, Palumbo GA (2023) ACVR1: a novel therapeutic target to treat anemia in myelofibrosis. Cancers (Basel) 16(1). https:\/\/doi.org\/10.3390\/cancers16010154","DOI":"10.3390\/cancers16010154"},{"issue":"9","key":"13_CR26","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","volume":"1823","author":"T Ganz","year":"2012","unstructured":"Ganz T, Nemeth E (2012) Hepcidin and iron homeostasis. Biochim Biophys Acta 1823(9):1434\u20131443. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.01.014","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"13_CR27","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1182\/blood-2008-02-139915","volume":"112","author":"T Ganz","year":"2008","unstructured":"Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M (2008) Immunoassay for human serum hepcidin. Blood 112(10):4292\u20134297. https:\/\/doi.org\/10.1182\/blood-2008-02-139915","journal-title":"Blood"},{"issue":"1","key":"13_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1179\/1607845414Y.0000000161","volume":"20","author":"BL Gaspar","year":"2015","unstructured":"Gaspar BL, Sharma P, Das R (2015) Anemia in malignancies: pathogenetic and diagnostic considerations. Hematology 20(1):18\u201325. https:\/\/doi.org\/10.1179\/1607845414Y.0000000161","journal-title":"Hematology"},{"issue":"23","key":"13_CR29","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1182\/blood-2015-12-639112","volume":"127","author":"D Girelli","year":"2016","unstructured":"Girelli D, Nemeth E, Swinkels DW (2016) Hepcidin in the diagnosis of iron disorders. Blood 127(23):2809\u20132813. https:\/\/doi.org\/10.1182\/blood-2015-12-639112","journal-title":"Blood"},{"issue":"1","key":"13_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12185-017-2373-3","volume":"107","author":"D Girelli","year":"2018","unstructured":"Girelli D, Ugolini S, Busti F, Marchi G, Castagna A (2018) Modern iron replacement therapy: clinical and pathophysiological insights. Int J Hematol 107(1):16\u201330. https:\/\/doi.org\/10.1007\/s12185-017-2373-3","journal-title":"Int J Hematol"},{"issue":"1","key":"13_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/path.5170","volume":"247","author":"MC Gomez-Puerto","year":"2019","unstructured":"Gomez-Puerto MC, Iyengar PV, Garc\u00eda de Vinuesa A, ten Dijke P, Sanchez-Duffhues G (2019) Bone morphogenetic protein receptor signal transduction in human disease. J Pathol 247(1):9\u201320. https:\/\/doi.org\/10.1002\/path.5170","journal-title":"J Pathol"},{"key":"13_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g6897","volume":"349","author":"LT Goodnough","year":"2014","unstructured":"Goodnough LT, Murphy MF (2014) Do liberal blood transfusions cause more harm than good? BMJ (Clinical research ed) 349:g6897. https:\/\/doi.org\/10.1136\/bmj.g6897","journal-title":"BMJ (Clinical research ed)"},{"issue":"9","key":"13_CR33","doi-asserted-by":"publisher","first-page":"EVIDoa2300189","DOI":"10.1056\/EVIDoa2300189","volume":"3","author":"JT Ha","year":"2024","unstructured":"Ha JT, Hiremath S, Jun M, Green SC, Wheeler DC, Coyne DW, Perkovic V, Badve SV (2024) Hypoxia-inducible factor prolyl hydroxylase inhibitors in kidney disease. NEJM Evid 3(9):EVIDoa2300189. https:\/\/doi.org\/10.1056\/EVIDoa2300189","journal-title":"NEJM Evid"},{"issue":"10","key":"13_CR34","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1164\/rccm.201110-1915CI","volume":"185","author":"SJ Hayden","year":"2012","unstructured":"Hayden SJ, Albert TJ, Watkins TR, Swenson ER (2012) Anemia in critical illness: insights into etiology, consequences, and management. Am J Respir Crit Care Med 185(10):1049\u20131057. https:\/\/doi.org\/10.1164\/rccm.201110-1915CI","journal-title":"Am J Respir Crit Care Med"},{"issue":"18","key":"13_CR35","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA\/ACC\/HFSA guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation 145(18):e895\u2013e1032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"issue":"Pt 6","key":"13_CR36","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1113\/jphysiol.2010.195057","volume":"589","author":"W Jelkmann","year":"2011","unstructured":"Jelkmann W (2011) Regulation of erythropoietin production. J Physiol 589(Pt 6):1251\u20131258. https:\/\/doi.org\/10.1113\/jphysiol.2010.195057","journal-title":"J Physiol"},{"issue":"2","key":"13_CR37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1084\/jem.20170396","volume":"215","author":"S Khalil","year":"2018","unstructured":"Khalil S, Delehanty L, Grado S, Holy M, White Z 3rd, Freeman K, Kurita R, Nakamura Y, Bullock G, Goldfarb A (2018) Iron modulation of erythropoiesis is associated with scribble-mediated control of the erythropoietin receptor. J Exp Med 215(2):661\u2013679. https:\/\/doi.org\/10.1084\/jem.20170396","journal-title":"J Exp Med"},{"issue":"3","key":"13_CR38","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1053\/j.gastro.2020.06.046","volume":"159","author":"CW Ko","year":"2020","unstructured":"Ko CW, Siddique SM, Patel A, Harris A, Sultan S, Altayar O, Falck-Ytter Y (2020) AGA clinical practice guidelines on the gastrointestinal evaluation of iron deficiency anemia. Gastroenterology 159(3):1085\u20131094. https:\/\/doi.org\/10.1053\/j.gastro.2020.06.046","journal-title":"Gastroenterology"},{"key":"13_CR39","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.freeradbiomed.2013.09.001","volume":"65","author":"TS Koskenkorva-Frank","year":"2013","unstructured":"Koskenkorva-Frank TS, Weiss G, Koppenol WH, Burckhardt S (2013) The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med 65:1174\u20131194. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.09.001","journal-title":"Free Radic Biol Med"},{"key":"13_CR40","doi-asserted-by":"publisher","unstructured":"Lanser L, Fuchs D, Scharnagl H, Grammer T, Kleber ME, M\u00e4rz W, Weiss G, Kurz K (2021a) Anemia of chronic disease in patients with cardiovascular disease. Front Cardiovasc Med 8(939). https:\/\/doi.org\/10.3389\/fcvm.2021.666638","DOI":"10.3389\/fcvm.2021.666638"},{"issue":"11","key":"13_CR41","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.3390\/nu13113732","volume":"13","author":"L Lanser","year":"2021","unstructured":"Lanser L, Fuchs D, Kurz K, Weiss G (2021b) Physiology and inflammation driven pathophysiology of iron homeostasis\u2014mechanistic insights into anemia of inflammation and its treatment. Nutrients 13(11):3732","journal-title":"Nutrients"},{"key":"13_CR42","doi-asserted-by":"publisher","unstructured":"Lanser L, Plaikner M, Schroll A, Burkert FR, Seiwald S, Fauser J, Petzer V, Bellmann-Weiler R, Fritsche G, Tancevski I, Duftner C, Pircher A, Seeber A, Zoller H, Kremser C, Henninger B, Weiss G (2023) Tissue iron distribution in patients with anemia of inflammation: results of a pilot study. Am J Hematol. https:\/\/doi.org\/10.1002\/ajh.26909","DOI":"10.1002\/ajh.26909"},{"issue":"1","key":"13_CR43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3324\/haematol.2016.150227","volume":"102","author":"C Latour","year":"2017","unstructured":"Latour C, Wlodarczyk MF, Jung G, Gineste A, Blanchard N, Ganz T, Roth MP, Coppin H, Kautz L (2017a) Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia. Haematologica 102(1):60\u201368. https:\/\/doi.org\/10.3324\/haematol.2016.150227","journal-title":"Haematologica"},{"issue":"21","key":"13_CR44","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1182\/blood-2017-07-795658","volume":"130","author":"C Latour","year":"2017","unstructured":"Latour C, Besson-Fournier C, Gourbeyre O, Meynard D, Roth M-P, Coppin H (2017b) Deletion of BMP6 worsens the phenotype of HJV-deficient mice and attenuates hepcidin levels reached after LPS challenge. Blood 130(21):2339\u20132343. https:\/\/doi.org\/10.1182\/blood-2017-07-795658","journal-title":"Blood"},{"issue":"5","key":"13_CR45","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/gutjnl-2015-309940","volume":"66","author":"T Lee","year":"2017","unstructured":"Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D (2017) Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut 66(5):863\u2013871. https:\/\/doi.org\/10.1136\/gutjnl-2015-309940","journal-title":"Gut"},{"issue":"9","key":"13_CR46","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1182\/blood-2010-10-315218","volume":"118","author":"SF Libregts","year":"2011","unstructured":"Libregts SF, Guti\u00e9rrez L, de Bruin AM, Wensveen FM, Papadopoulos P, van Ijcken W, Ozg\u00fcr Z, Philipsen S, Nolte MA (2011) Chronic IFN-\u03b3 production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1\/PU.1 axis. Blood 118(9):2578\u20132588. https:\/\/doi.org\/10.1182\/blood-2010-10-315218","journal-title":"Blood"},{"issue":"10","key":"13_CR47","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1182\/blood-2002-08-2459","volume":"101","author":"S Ludwiczek","year":"2003","unstructured":"Ludwiczek S, Aigner E, Theurl I, Weiss GN (2003) Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 101(10):4148\u20134154. https:\/\/doi.org\/10.1182\/blood-2002-08-2459","journal-title":"Blood"},{"issue":"1","key":"13_CR48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.kint.2015.10.002","volume":"89","author":"IC Macdougall","year":"2016","unstructured":"Macdougall IC, Bircher AJ, Eckardt KU, Obrador GT, Pollock CA, Stenvinkel P, Swinkels DW, Wanner C, Weiss G, Chertow GM (2016) Iron management in chronic kidney disease: conclusions from a \"kidney disease: improving global outcomes\" (KDIGO) controversies conference. Kidney Int 89(1):28\u201339. https:\/\/doi.org\/10.1016\/j.kint.2015.10.002","journal-title":"Kidney Int"},{"issue":"19","key":"13_CR49","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1182\/blood.2021013472","volume":"140","author":"O Marques","year":"2022","unstructured":"Marques O, Weiss G, Muckenthaler MU (2022) The role of iron in chronic inflammatory diseases: from mechanisms to treatment options in anemia of inflammation. Blood 140(19):2011\u20132023. https:\/\/doi.org\/10.1182\/blood.2021013472","journal-title":"Blood"},{"issue":"4","key":"13_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ajh.21090","volume":"83","author":"AE Mast","year":"2008","unstructured":"Mast AE, Blinder MA, Dietzen DJ (2008) Reticulocyte hemoglobin content. Am J Hematol 83(4):307\u2013310. https:\/\/doi.org\/10.1002\/ajh.21090","journal-title":"Am J Hematol"},{"issue":"2","key":"13_CR51","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.3324\/haematol.2014.111484","volume":"100","author":"C Mayeur","year":"2015","unstructured":"Mayeur C, Kolodziej SA, Wang A, Xu X, Lee A, Yu PB, Shen J, Bloch KD, Bloch DB (2015) Oral administration of a bone morphogenetic protein type I receptor inhibitor prevents the development of anemia of inflammation. Haematologica 100(2):e68\u2013e71. https:\/\/doi.org\/10.3324\/haematol.2014.111484","journal-title":"Haematologica"},{"issue":"36","key":"13_CR52","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, CSP L, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, Group ESD (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"13_CR53","unstructured":"Mcmurray J, Parfrey PS, Adamson JW, Aljama P, Berns JS, Bohlius J, Dr\u00fceke TB, Finkelstein FO, Fishbane S, Ganz T, Macdougall IC, McDonald RA, McMahon LP, Obrador GT, Strippoli GFM, Weiss G, Wi\u0119cek A (2012) KDIGO clinical practice guideline for anemia in chronic kidney disease"},{"issue":"11","key":"13_CR54","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1073\/pnas.88.11.4946","volume":"88","author":"LL Miller","year":"1991","unstructured":"Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM (1991) Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc Natl Acad Sci 88(11):4946\u20134950. https:\/\/doi.org\/10.1073\/pnas.88.11.4946","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"13_CR55","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/ajh.20644","volume":"81","author":"BL Mitlyng","year":"2006","unstructured":"Mitlyng BL, Singh JA, Furne JK, Ruddy J, Levitt MD (2006) Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases. Am J Hematol 81(6):432\u2013438. https:\/\/doi.org\/10.1002\/ajh.20644","journal-title":"Am J Hematol"},{"issue":"5","key":"13_CR56","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1096\/fasebj.3.5.2784116","volume":"3","author":"LL Moldawer","year":"1989","unstructured":"Moldawer LL, Marano MA, Wei H, Fong Y, Silen ML, Kuo G, Manogue KR, Vlassara H, Cohen H, Cerami A, Lowry SF (1989) Cachectin\/tumor necrosis factor-\u03b1 alters red blood cell kinetics and induces anemia in vivo. FASEB J 3(5):1637\u20131643. https:\/\/doi.org\/10.1096\/fasebj.3.5.2784116","journal-title":"FASEB J"},{"issue":"3","key":"13_CR57","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2016.12.034","volume":"168","author":"MU Muckenthaler","year":"2017","unstructured":"Muckenthaler MU, Rivella S, Hentze MW, Galy B (2017) A red carpet for iron metabolism. Cell 168(3):344\u2013361. https:\/\/doi.org\/10.1016\/j.cell.2016.12.034","journal-title":"Cell"},{"issue":"2","key":"13_CR58","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/anae.13773","volume":"72","author":"M Mu\u00f1oz","year":"2017","unstructured":"Mu\u00f1oz M, Acheson AG, Auerbach M, Besser M, Habler O, Kehlet H, Liumbruno GM, Lasocki S, Meybohm P, Rao Baikady R, Richards T, Shander A, So-Osman C, Spahn DR, Klein AA (2017) International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 72(2):233\u2013247. https:\/\/doi.org\/10.1111\/anae.13773","journal-title":"Anaesthesia"},{"key":"13_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100864","volume":"75","author":"M Nairz","year":"2020","unstructured":"Nairz M, Weiss G (2020) Iron in infection and immunity. Mol Asp Med 75:100864. https:\/\/doi.org\/10.1016\/j.mam.2020.100864","journal-title":"Mol Asp Med"},{"issue":"3","key":"13_CR60","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.micinf.2011.10.005","volume":"14","author":"M Nairz","year":"2012","unstructured":"Nairz M, Sonnweber T, Schroll A, Theurl I, Weiss G (2012) The pleiotropic effects of erythropoietin in infection and inflammation. Microbes Infect 14(3):238\u2013246. https:\/\/doi.org\/10.1016\/j.micinf.2011.10.005","journal-title":"Microbes Infect"},{"key":"13_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ckj\/sfae051","volume":"17","author":"T Nakanishi","year":"2024","unstructured":"Nakanishi T, Kuragano T (2024) Growing concerns about using hypoxia-inducible factor prolyl hydroxylase inhibitors for the treatment of renal anemia. Clin Kidney J 17:3. https:\/\/doi.org\/10.1093\/ckj\/sfae051","journal-title":"Clin Kidney J"},{"key":"13_CR62","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000496636","volume":"198","author":"T Nakanishi","year":"2019","unstructured":"Nakanishi T, Kimura T, Kuragano T (2019) The Hepcidin-anemia Axis: pathogenesis of anemia in chronic kidney disease. Contrib Nephrol 198:124\u2013134. https:\/\/doi.org\/10.1159\/000496636","journal-title":"Contrib Nephrol"},{"issue":"5704","key":"13_CR63","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306(5704):2090\u20132093. https:\/\/doi.org\/10.1126\/science.1104742","journal-title":"Science"},{"issue":"1","key":"13_CR64","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/nu10010082","volume":"10","author":"OH Nielsen","year":"2018","unstructured":"Nielsen OH, Soendergaard C, Vikner ME, Weiss G (2018) Rational management of iron-deficiency anaemia in inflammatory bowel disease. Nutrients 10(1):82","journal-title":"Nutrients"},{"issue":"3","key":"13_CR65","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ijcard.2011.07.045","volume":"164","author":"DO Okonko","year":"2013","unstructured":"Okonko DO, Marley SB, Anker SD, Poole-Wilson PA, Gordon MY (2013) Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction. Int J Cardiol 164(3):359\u2013364. https:\/\/doi.org\/10.1016\/j.ijcard.2011.07.045","journal-title":"Int J Cardiol"},{"issue":"4","key":"13_CR66","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/ph11040135","volume":"11","author":"V Petzer","year":"2018","unstructured":"Petzer V, Theurl I, Weiss G (2018) Established and emerging concepts to treat imbalances of iron homeostasis in inflammatory diseases. Pharmaceuticals (Basel) 11(4):135. https:\/\/doi.org\/10.3390\/ph11040135","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"13_CR67","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1182\/blood.2019004653","volume":"136","author":"V Petzer","year":"2020","unstructured":"Petzer V, Tymoszuk P, Asshoff M, Carvalho J, Papworth J, Deantonio C, Bayliss L, Wake MS, Seifert M, Brigo N, Valente de Souza L, Hilbe R, Grubwieser P, Demetz E, Dichtl S, Volani C, Berger S, B\u00f6hm F, Hoffmann A, Pfeifhofer-Obermair C, von Raffay L, Sopper S, Arndt S, Bosserhoff A, Kautz L, Perrier P, Nairz M, Wolf D, Weiss G, Germaschewski V, Theurl I (2020) A fully human anti-BMP6 antibody reduces the need for erythropoietin in rodent models of the anemia of chronic disease. Blood 136(9):1080\u20131090. https:\/\/doi.org\/10.1182\/blood.2019004653","journal-title":"Blood"},{"issue":"8","key":"13_CR68","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1182\/blood-2011-11-391219","volume":"119","author":"AM Prentice","year":"2012","unstructured":"Prentice AM, Doherty CP, Abrams SA, Cox SE, Atkinson SH, Verhoef H, Armitage AE, Drakesmith H (2012) Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood 119(8):1922\u20131928. https:\/\/doi.org\/10.1182\/blood-2011-11-391219","journal-title":"Blood"},{"issue":"3","key":"13_CR69","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/ejh.13560","volume":"106","author":"JC Purdy","year":"2021","unstructured":"Purdy JC, Shatzel JJ (2021) The hematologic consequences of obesity. Eur J Haematol 106(3):306\u2013319. https:\/\/doi.org\/10.1111\/ejh.13560","journal-title":"Eur J Haematol"},{"issue":"12","key":"13_CR70","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/ajg.2013.335","volume":"108","author":"W Reinisch","year":"2013","unstructured":"Reinisch W, Staun M, Tandon RK, Altorjay I, Thillainayagam AV, Gratzer C, Nijhawan S, Thomsen LL (2013) A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED). Am J Gastroenterol 108(12):1877\u20131888. https:\/\/doi.org\/10.1038\/ajg.2013.335","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"13_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212023","volume":"14","author":"L Renders","year":"2019","unstructured":"Renders L, Budde K, Rosenberger C, van Swelm R, Swinkels D, Dellanna F, Feuerer W, Wen M, Erley C, Bader B, Sommerer C, Schaier M, Meurer K, Matis L (2019) First-in-human phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis. PLoS One 14(3):e0212023. https:\/\/doi.org\/10.1371\/journal.pone.0212023","journal-title":"PLoS One"},{"issue":"5","key":"13_CR72","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/bcp.13877","volume":"85","author":"M Sheetz","year":"2019","unstructured":"Sheetz M, Barrington P, Callies S, Berg PH, McColm J, Marbury T, Decker B, Dyas GL, Truhlar SME, Benschop R, Leung D, Berg J, Witcher DR (2019) Targeting the hepcidin\u2013ferroportin pathway in anaemia of chronic kidney disease. Br J Clin Pharmacol 85(5):935\u2013948. https:\/\/doi.org\/10.1111\/bcp.13877","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"13_CR73","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/ajh.22108","volume":"86","author":"BS Skikne","year":"2011","unstructured":"Skikne BS, Punnonen K, Caldron PH, Bennett MT, Rehu M, Gasior GH, Chamberlin JS, Sullivan LA, Bray KR, Southwick PC (2011) Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR\/log ferritin index. Am J Hematol 86(11):923\u2013927. https:\/\/doi.org\/10.1002\/ajh.22108","journal-title":"Am J Hematol"},{"issue":"11","key":"13_CR74","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1136\/gutjnl-2021-325210","volume":"70","author":"J Snook","year":"2021","unstructured":"Snook J, Bhala N, Beales ILP, Cannings D, Kightley C, Logan RP, Pritchard DM, Sidhu R, Surgenor S, Thomas W, Verma AM, Goddard AF (2021) British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut 70(11):2030\u20132051. https:\/\/doi.org\/10.1136\/gutjnl-2021-325210","journal-title":"Gut"},{"issue":"11","key":"13_CR75","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.15252\/embr.201540558","volume":"16","author":"MP Soares","year":"2015","unstructured":"Soares MP, Weiss G (2015) The iron age of host\u2013microbe interactions. EMBO Rep 16(11):1482\u20131500. https:\/\/doi.org\/10.15252\/embr.201540558","journal-title":"EMBO Rep"},{"issue":"8","key":"13_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203396","volume":"13","author":"T Sonnweber","year":"2018","unstructured":"Sonnweber T, Nairz M, Theurl I, Petzer V, Tymoszuk P, Haschka D, Rieger E, Kaessmann B, Deri M, Watzinger K, Steringer-Mascherbauer R, Tancevski I, Weiss G, L\u00f6ffler-Ragg J (2018) The crucial impact of iron deficiency definition for the course of precapillary pulmonary hypertension. PLoS One 13(8):e0203396. https:\/\/doi.org\/10.1371\/journal.pone.0203396","journal-title":"PLoS One"},{"issue":"5","key":"13_CR77","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1182\/blood-2017-07-746446","volume":"131","author":"R Stauder","year":"2018","unstructured":"Stauder R, Valent P, Theurl I (2018) Anemia at older age: etiologies, clinical implications, and management. Blood 131(5):505\u2013514. https:\/\/doi.org\/10.1182\/blood-2017-07-746446","journal-title":"Blood"},{"issue":"8","key":"13_CR78","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.3390\/nu5083034","volume":"5","author":"AU Steinbicker","year":"2013","unstructured":"Steinbicker AU, Muckenthaler MU (2013) Out of balance--systemic iron homeostasis in iron-related disorders. Nutrients 5(8):3034\u20133061. https:\/\/doi.org\/10.3390\/nu5083034","journal-title":"Nutrients"},{"issue":"18","key":"13_CR79","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.1182\/blood-2010-10-313064","volume":"117","author":"AU Steinbicker","year":"2011","unstructured":"Steinbicker AU, Sachidanandan C, Vonner AJ, Yusuf RZ, Deng DY, Lai CS, Rauwerdink KM, Winn JC, Saez B, Cook CM, Szekely BA, Roy CN, Seehra JS, Cuny GD, Scadden DT, Peterson RT, Bloch KD, Yu PB (2011) Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood 117(18):4915\u20134923. https:\/\/doi.org\/10.1182\/blood-2010-10-313064","journal-title":"Blood"},{"issue":"11","key":"13_CR80","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1016\/s2352-3026(17)30182-5","volume":"4","author":"NU Stoffel","year":"2017","unstructured":"Stoffel NU, Cercamondi CI, Brittenham G, Zeder C, Geurts-Moespot AJ, Swinkels DW, Moretti D, Zimmermann MB (2017) Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol 4(11):e524\u2013e533. https:\/\/doi.org\/10.1016\/s2352-3026(17)30182-5","journal-title":"Lancet Haematol"},{"issue":"10","key":"13_CR81","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/ndt\/gfae075","volume":"39","author":"S Stoumpos","year":"2024","unstructured":"Stoumpos S, Crowe K, Sarafidis P, Barratt J, Bolignano D, Del Vecchio L, Ma\u0142yszko J, Wi\u0119cek A, Ortiz A, Cozzolino M (2024) Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a clinical practice document by the European renal best practice board of the European renal association. Nephrol Dialysis Transplant 39(10):1710\u20131730. https:\/\/doi.org\/10.1093\/ndt\/gfae075","journal-title":"Nephrol Dialysis Transplant"},{"issue":"7","key":"13_CR82","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/ndt\/gfs584","volume":"28","author":"CC Sun","year":"2013","unstructured":"Sun CC, Vaja V, Chen S, Theurl I, Stepanek A, Brown DE, Cappellini MD, Weiss G, Hong CC, Lin HY, Babitt JL (2013) A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats. Nephrol Dial Transplant 28(7):1733\u20131743. https:\/\/doi.org\/10.1093\/ndt\/gfs584","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"13_CR83","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1182\/blood.V90.6.2244","volume":"90","author":"S Taniguchi","year":"1997","unstructured":"Taniguchi S, Dai CH, Price JO, Krantz SB (1997) Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells. Blood 90(6):2244\u20132252","journal-title":"Blood"},{"issue":"10","key":"13_CR84","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1182\/blood-2005-08-3364","volume":"107","author":"I Theurl","year":"2006","unstructured":"Theurl I, Mattle V, Seifert M, Mariani M, Marth C, Weiss G (2006) Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood 107(10):4142\u20134148. https:\/\/doi.org\/10.1182\/blood-2005-08-3364","journal-title":"Blood"},{"issue":"4","key":"13_CR85","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1182\/blood-2007-05-090019","volume":"111","author":"I Theurl","year":"2008","unstructured":"Theurl I, Theurl M, Seifert M, Mair S, Nairz M, Rumpold H, Zoller H, Bellmann-Weiler R, Niederegger H, Talasz H, Weiss G (2008) Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 111(4):2392\u20132399. https:\/\/doi.org\/10.1182\/blood-2007-05-090019","journal-title":"Blood"},{"issue":"21","key":"13_CR86","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1182\/blood-2008-12-195651","volume":"113","author":"I Theurl","year":"2009","unstructured":"Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G (2009) Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 113(21):5277\u20135286. https:\/\/doi.org\/10.1182\/blood-2008-12-195651","journal-title":"Blood"},{"issue":"18","key":"13_CR87","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1182\/blood-2011-03-345066","volume":"118","author":"I Theurl","year":"2011","unstructured":"Theurl I, Schroll A, Sonnweber T, Nairz M, Theurl M, Willenbacher W, Eller K, Wolf D, Seifert M, Sun CC, Babitt JL, Hong CC, Menhall T, Gearing P, Lin HY, Weiss G (2011) Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood 118(18):4977\u20134984. https:\/\/doi.org\/10.1182\/blood-2011-03-345066","journal-title":"Blood"},{"issue":"9","key":"13_CR88","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3324\/haematol.2013.099481","volume":"99","author":"M Theurl","year":"2014","unstructured":"Theurl M, Nairz M, Schroll A, Sonnweber T, Asshoff M, Haschka D, Seifert M, Willenbacher W, Wilflingseder D, Posch W, Murphy AT, Witcher DR, Theurl I, Weiss G (2014) Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats. Haematologica 99(9):1516\u20131524. https:\/\/doi.org\/10.3324\/haematol.2013.099481","journal-title":"Haematologica"},{"issue":"8","key":"13_CR89","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nm.4146","volume":"22","author":"I Theurl","year":"2016","unstructured":"Theurl I, Hilgendorf I, Nairz M, Tymoszuk P, Haschka D, Asshoff M, He S, Gerhardt LM, Holderried TA, Seifert M, Sopper S, Fenn AM, Anzai A, Rattik S, McAlpine C, Theurl M, Wieghofer P, Iwamoto Y, Weber GF, Harder NK, Chousterman BG, Arvedson TL, McKee M, Wang F, Lutz OM, Rezoagli E, Babitt JL, Berra L, Prinz M, Nahrendorf M, Weiss G, Weissleder R, Lin HY, Swirski FK (2016) On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver. Nat Med 22(8):945\u2013951. https:\/\/doi.org\/10.1038\/nm.4146","journal-title":"Nat Med"},{"issue":"4","key":"13_CR90","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.4049\/jimmunol.169.4.2204","volume":"169","author":"H Tilg","year":"2002","unstructured":"Tilg H, Ulmer H, Kaser A, Weiss G (2002) Role of IL-10 for induction of anemia during inflammation. J Immunol 169(4):2204\u20132209","journal-title":"J Immunol"},{"issue":"1","key":"13_CR91","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13045-017-0427-x","volume":"10","author":"S Vadhan-Raj","year":"2017","unstructured":"Vadhan-Raj S, Abonour R, Goldman JW, Smith DA, Slapak CA, Ilaria RL Jr, Tiu RV, Wang X, Callies S, Cox J, Tuttle JL, Lau Y-K, Roeland EJ (2017) A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia. J Hematol Oncol 10(1):73\u201373. https:\/\/doi.org\/10.1186\/s13045-017-0427-x","journal-title":"J Hematol Oncol"},{"key":"13_CR92","doi-asserted-by":"publisher","unstructured":"Valente de Souza L, Hoffmann A, Weiss G (2020) Impact of bacterial infections on erythropoiesis. Expert Rev Anti Infect Ther:1\u201315. https:\/\/doi.org\/10.1080\/14787210.2021.1841636","DOI":"10.1080\/14787210.2021.1841636"},{"issue":"1","key":"13_CR93","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","volume":"7","author":"S von Haehling","year":"2019","unstructured":"von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker SD (2019) Iron deficiency in heart failure: an overview. JACC. Heart Failure 7(1):36\u201346. https:\/\/doi.org\/10.1016\/j.jchf.2018.07.015","journal-title":"Heart Failure"},{"issue":"4","key":"13_CR94","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/j.seminhematol.2015.07.004","volume":"52","author":"G Weiss","year":"2015","unstructured":"Weiss G (2015) Anemia of chronic disorders: new diagnostic tools and new treatment strategies. Semin Hematol 52(4):313\u2013320. https:\/\/doi.org\/10.1053\/j.seminhematol.2015.07.004","journal-title":"Semin Hematol"},{"issue":"10","key":"13_CR95","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra041809","volume":"352","author":"G Weiss","year":"2005","unstructured":"Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352(10):1011\u20131023. https:\/\/doi.org\/10.1056\/NEJMra041809","journal-title":"N Engl J Med"},{"issue":"4","key":"13_CR96","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrrheum.2012.183","volume":"9","author":"G Weiss","year":"2013","unstructured":"Weiss G, Schett G (2013) Anaemia in inflammatory rheumatic diseases. Nat Rev Rheumatol 9(4):205\u2013215. https:\/\/doi.org\/10.1038\/nrrheum.2012.183","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"13_CR97","doi-asserted-by":"publisher","first-page":"420","DOI":"10.4049\/jimmunol.158.1.420","volume":"158","author":"G Weiss","year":"1997","unstructured":"Weiss G, Bogdan C, Hentze MW (1997) Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol 158(1):420\u2013425","journal-title":"J Immunol"},{"issue":"1","key":"13_CR98","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","volume":"133","author":"G Weiss","year":"2019","unstructured":"Weiss G, Ganz T, Goodnough LT (2019) Anemia of inflammation. Blood 133(1):40\u201350. https:\/\/doi.org\/10.1182\/blood-2018-06-856500","journal-title":"Blood"},{"key":"13_CR99","doi-asserted-by":"publisher","unstructured":"Zoller H, Schaefer B, Glodny B (2017) Iron-induced hypophosphatemia: an emerging complication. Curr Opin Nephrol Hypertens. https:\/\/doi.org\/10.1097\/MNH.0000000000000329","DOI":"10.1097\/MNH.0000000000000329"}],"container-title":["Advances in Experimental Medicine and Biology","Iron Metabolism in Human Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-92033-2_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T18:55:59Z","timestamp":1776797759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-92033-2_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031920325","9783031920332"],"references-count":99,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-92033-2_13","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"3 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}